PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Midas International FZE

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Midas International Strikes Venture Capital Deal with Orphan Drug Company - Dubai based investment firm takes position in promising U.S. biotech industry companies pursuing cures for untreated ailments - MidasWorldwide.com
Midas International Strikes Venture Capital Deal with Orphan Drug Company

 

NewswireToday - /newswire/ - Dubai, UAE, United Arab Emirates, 2008/11/13 - Dubai based investment firm takes position in promising U.S. biotech industry companies pursuing cures for untreated ailments - MidasWorldwide.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Midas International announced today that it has come to an agreement for up to $35 million in venture capital financing for two separate companies involved in the development of orphan drugs (Drugs for diseases that afflict small numbers of people). At this time details of the agreements were not disclosed, however it has been disclosed that the first round of funding would come immediately from Midas International with the later rounds coming from a consortium of their clients.

“Midas International has long supported the biotech industry. We believe that not only is it the right thing to do as global citizens, but from a business perspective as well,” said Kenneth Emerson, Director of Business development. “Several years ago we funded a small biotech firm in the U.S. that was developing a drug to protect the central nervous system. That drug is now used in treatments of more than a dozen diseases including Multiple Sclerosis.”

The companies that Midas has agreed to fund will both be receiving matching grants from a U.S. Foundation. The Dollar for Dollar agreement allows companies to effectively pursue treatments to ailments that often go untreated. Midas in return for its early round funding efforts will have a seat on the board of both companies and a right of first refusal on certain next steps the companies may take. The business model for investment into Orphan Drugs has been in effect since the 1983 Orphan Drug Act in the US granted special patent rights. Similar laws protect and promote this vital research and the drugs that are developed as a result in the EU.

Midas International, FZE (midasworldwide.com) is an investment banking, financial consulting and brokerage firm offering investment solutions, asset allocation strategies and analysis on equities and fixed income securities. The Dubai based investment firm has satellite offices in Hong Kong, London and Sydney.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Financial/Legal/Venture Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Midas International FZE

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Financial/Legal/Venture articles,
CATCH Visitors via Your Competitors Announcements!


Midas International Strikes Venture Capital Deal with Orphan Drug Company

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Andy Scofield - MidasWorldwide.com 
+971 4 509 6841 ascofield[.]midasworldwide.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Midas International FZE securities in any jurisdiction including any other companies listed or named in this release.

Financial/Legal/Venture via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Midas International FZE / Company Profile


Read Financial/Legal/Venture Most Recent Related Newswires:

Bosnia, Privatized Krajina Insurance Osiguranje is Nationalized - Investors Start Arbitration
TRA Announces Acquisition of Retirement Planning, Inc.
Lexis Advance Wins SIIA Business Technology CODiE Award
FTI Consulting Launches Specialist Director Support Services in the Cayman Islands
LexisNexis Spotlights New Innovations, Analytics & A.I. Offerings at AALL 2017
LexisNexis Digital Library Announces New Agreement with ALM
TRA Hires Tiffany Hanks as Regional Sales Consultant
LexisNexis® Expands Media Intelligence Portfolio with LexisNexis® Media Contacts Solution
LexisNexis Wins 21 Awards from Two Prestigious Publications
Frost & Sullivan Commends AutoGravity for Transforming Automotive Financing Industry
NYSE Governance Services and FTI Consulting Announce 17th Annual Corporate Law Firms Rankings
FTI Consulting and Asia Group Advisors Formalise Affiliate Relationship Across Asia Pacific
LexisNexis Receives 2017 Corporate Leadership Award from Freedom House for Activism in Advancing the Rule of Law
Societe Generale Named ‘Distinguished Provider of Transaction Banking Services’ by FImetrix
ALM Wins 2 Awards at 2017 Jesse H. Neal Awards

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)